New leakproof vials offer enhanced sample and user safety
Thermo's Samco Clicktainer vials provide secure and reliable sample collection and transport.
A new series of leakproof vials has been developed to provide sample protection and user safety by enabling correct cap application every time. The unique lid-lock design of the Thermo Scientific Samco Clicktainer vials makes them ideal for the secure transport of valuable and often hazardous clinical, research and forensic samples.
The new Samco Clicktainer vials are designed for the secure collection and handling of fluid, solid and powder samples, including urine, sputum and stool specimens. They bear the CE mark and are compliant with applicable FDA regulations. They also are 95kPa leak and pressure tested in accordance with standards BS EN 14401 and 14254, respectively, and are tested to support their use in hospital pneumatic transport systems.
"Enabling the safe and secure collection and transportation of specimen samples is essential for the efficient operation of many laboratory types where leakages can not only lead to inconveniences associated with lost work, but can also be hazardous for laboratory personnel," said Eric Roman, president, laboratory products, Thermo Fisher Scientific. "Our new Samco Clicktainer vials are rigorously tested to ensure they are leakproof, and our click seal system provides users with peace of mind that their specimens are secure following collection."
Available in 120 mL and 90 mL formats with an optional built-in temperature strip, users simply turn the lid gently past the lock symbol and an audible 'click' sound will signify the lid is fully sealed. The click mechanism is also tactile, and clear markers on the lid and vial also indicate when the lid is correctly closed. As such, users can be confident their samples are safe, while the durable tab design reduces the risk of torn gloves or break-off leading to potential contamination of the sample.
The wide 53-mm opening is designed for easy specimen collection and handling, and the cap is available in multiple colors for sample differentiation and management. In addition, the vials are available gamma irradiated to a sterility assurance level (SAL) of 10-6 for routine microbiology and more sensitive applications or non-sterile for general use.
The Clicktainer vials are compliant with the requirements of In Vitro Diagnostic Device Directive 98/79/EC.
Related News
-
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Pharma Supply Chain People Moves
The latest appointments, promotions, and structural changes across the pharmaceutical supply chain. -
News Drug prices agreed upon as part of the US Inflation Reduction Act
The Inflation Reduction Act brought into constitution by the Biden administation in 2022, which proposed a drug price negotiation between the government and pharmaceutical companies, has reached it's first agreement. -
News BIOSECURE Act continues to loom over Chinese pharma manufacturers
With the US BIOSECURE Act on its way to passing into legislation, Chinese companies are facing declining revenues within the first half of 2024 as US pharmaceutical and healthcare companies pull their businesses from the country. -
News Ophthalmologic drug product Eylea faces biosimilar threats after FDA approvals
Regeneron Pharmaceutical’s blockbuster ophthalmology drug Eylea is facing biosimilar competition as the US FDA approves Biocon’s Yesafili and Samsung Bioepis/Biogen’s Opuviz. -
News ONO Pharmaceutical expands oncology portfolio with acquisition of Deciphera
ONO Pharmaceutical, out of Japan, is in the process of acquiring cancer-therapy maker Deciphera Pharmaceuticals for US$2.4 billion. -
News First offers for pharma from Medicare drug price negotiations
Ten high-cost drugs from various pharma manufacturers are in pricing negotiations in a first-ever for the US Medicare program. President Biden’s administration stated they have responded to the first round of offers. -
News Eli Lilly’s Zepbound makes leaps and bounds in weight-loss drug market
In the last week, Eli Lilly has announced their partnership with Amazon.com’s pharmacy unit to deliver prescriptions of Zepbound. Zepbound has also surpassed Novo Nordisk’s Wegovy for the number of prescriptions for the week of March 8.&nbs...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance